Clinical Trials Logo

Chronic Fatigue Syndrome clinical trials

View clinical trials related to Chronic Fatigue Syndrome.

Filter by:

NCT ID: NCT00478465 Completed - Clinical trials for Chronic Fatigue Syndrome

Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)

Start date: May 2007
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study determine whether the drug valganciclovir has a significant and real benefit on the central core of symptoms experienced by patients who have high titers to EBV and HHV-6 and are experiencing long-standing fatigue and cognitive impairment (CFS). In addition, to characterize a quantifiable biological marker in these patients that will facilitate the identification of those likely to respond to valganciclovir and will make it possible to assess response to treatment.

NCT ID: NCT00468013 Completed - Fibromyalgia Clinical Trials

A Computer-Based Intervention for Medically Unexplained Physical Symptoms

Start date: March 2007
Phase: N/A
Study type: Interventional

In this study 60 people with medically unexplained physical symptoms (MUPS) will receive either a 6-session resilience skill building intervention provided fully online or a weekly computerized journaling assignment. Both programs can be completed from home. Participants will complete questionnaires both before and after the intervention and changes in symptoms, mood and satisfaction with life will be assessed.

NCT ID: NCT00433355 Completed - Clinical trials for Chronic Fatigue Syndrome

Epstein-Barr Virus as a Possible Cause for Chronic Fatigue Syndrome

Start date: January 2007
Phase: N/A
Study type: Observational

The purpose of this study is to understand what causes a continuing fatigue for a long time with a number of symptoms occurring at the same time (Chronic Fatigue Syndrome-CFS). Epstein Barr Virus is among the group of viruses that have been associated with a continuing fatigue for a long time with a number of symptoms occurring at the same time, but the cause is still unknown.

NCT ID: NCT00252629 Completed - Clinical trials for Chronic Fatigue Syndrome

Sleep Disordered Breathing in Gulf War Illness and the Effect of Nasal CPAP Treatment

Start date: November 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to determine any sleep disordered breathing in veterans with Gulf War Syndrome (GWS) and compare it to healthy normal asymptomatic Gulf War veterans. This study will also determine the effect of treatment with continuous positive airway pressure on veterans with Gulf War Syndrome. 1. The investigators hypothesize that sleep complaints (insomnia, un-refreshing sleep and daytime fatigue) among GWS patients are related to increased sleep fragmentation secondary to the presence of sleep disordered breathing in GWS patients. 2. The investigators hypothesize that increased collapsibility of the upper airway during sleep with the development of inspiratory flow limitation (IFL) and sleep disordered breathing causes the increased sleep fragmentation in GWS patients. 3. The investigators hypothesize that correction of IFL and sleep disordered breathing in GWS patients will result in an improvement of their sleep quality resulting in an improvement of their sleep complaints and other functional symptoms.

NCT ID: NCT00215813 Available - Clinical trials for Chronic Fatigue Syndrome

Ampligen in Chronic Fatigue Syndrome

Start date: n/a
Phase:
Study type: Expanded Access

This is an open label study of Ampligen in patients with chronic fatigue syndrome.

NCT ID: NCT00215800 Completed - Clinical trials for Chronic Fatigue Syndrome

The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome

Start date: December 1998
Phase: Phase 3
Study type: Interventional

multi-center, double-blind, randomized, placebo-controlled study of the safety and efficacy.

NCT ID: NCT00100412 Completed - Clinical trials for Post-Traumatic Stress Disorder

Hyporeactivity and Gulf War Illness

Start date: October 1999
Phase: N/A
Study type: Interventional

This research project is a follow-up to the prior VA-funded study that found that chronic fatigue reported by many Gulf War veterans may be a symptom of dysfunctional cardiovascular stress response regulation. Specifically, ill veterans had diminished autonomic responses during demanding psychosocial tasks involving high level cognitive processing and emotional stress. There was a close relationship between clinical status of ill veterans and their inability to mount an appropriate physiological response under stress. The main objective of the present investigation is to determine the specific mechanism through which this abnormality may contribute to Gulf War-related chronic fatigue. We also observed that Gulf veterans with posttraumatic stress disorder (PTSD) had the most dampened autonomic activation to stressors involving higher brain activities. The second major focus of this study is to explore the role of a psychiatric disorder, specifically PTSD, as a factor in abnormalities in stress response regulation. This aspect of the study may also provide pertinent information as to the role of stress of military deployment as a contributing factor in post-Gulf War illnesses.

NCT ID: NCT00071162 Active, not recruiting - Depression Clinical Trials

Genetics of Fibromyalgia

Start date: September 1999
Phase: N/A
Study type: Observational

The Fibromyalgia Family Study identifies and collects blood samples from families with two or more members affected with Fibromyalgia Syndrome (FMS). The primary goal of the study is to identify genes that predispose people to FMS and/or symptoms related to FMS; identifying these genes may lead to a better understanding of the disease and more effective treatments.

NCT ID: NCT00032461 Completed - Fibromyalgia Clinical Trials

Compare the Medical Conditions of Gulf War Veterans to Non-Deployed Veterans

Start date: November 1998
Phase: N/A
Study type: Observational

Primary Hypothesis: Gulf War veterans will have an equal prevalence or mean level of the following medical and psychological conditions frequently reported in the literature compared to a control group of nondeployed veterans: (1) chronic fatigue syndrome, (2) fibromyalgia, (3) post-traumatic stress disorder, (4) neurologic abnormalities, including peripheral neuropathy and cognitive dysfunction, and (5) general health status.